Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Murphy-Chutorian Douglas
 2. Date of Event Requiring Statement (Month/Day/Year)
02/20/2014		 3. Issuer Name and Ticker or Trading Symbol
Semler Scientific, Inc. [SMLR]
(Last)
(First)
(Middle)
C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST.		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
02/20/2014
(Street)

PORTLAND, OR 97210		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Option (right to buy) 11/21/2012 11/22/2022 Common Stock 20,000 $ 0.52 D  
Series A Preferred Stock Warrant (right to buy) (1) 06/07/2012 07/31/2016 Common Stock 16,390 $ 4.5 D  
Series A Preferred Stock Warrant (right to buy) (1) 06/07/2012 07/31/2016 Common Stock 22,517 $ 4.5 D  
Series A Preferred Stock Warrant (right to buy) (1) 08/31/2012 07/31/2016 Common Stock 29,890 $ 4.5 D  
Series A Preferred Stock Warrant (right to buy) (1) 07/31/2012 07/31/2016 Common Stock 65,542 $ 4.5 D  
Series A Preferred Stock Warrant (right to buy) (1) 07/31/2013 07/31/2016 Common Stock 60,000 $ 4.5 D  
Series A-1 Preferred Stock Warrant (right to buy) (1) 06/07/2012 06/30/2023 Common Stock 16,875 $ 4 D  
Series A-2 Preferred Stock Warrant (right to buy) (1) 06/07/2012 06/30/2022 Common Stock 25,000 $ 2 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Murphy-Chutorian Douglas
C/O SEMLER SCIENTIFIC, INC.
2330 NW EVERETT ST.
PORTLAND, OR 97210		   X     Chief Executive Officer  

Signatures

/s/ Douglas Murphy-Chutorian 09/21/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These warrant will become exercisable for shares of Issuer's common stock upon Issuer's initial public offering ("IPO"). These warrants will remain outstanding following the IPO and not be cashlessly exercised in connection with the IPO.
 
Remarks:
This amendment is being filed to correct the maturity date of the warrants exercisable 06/07/2012, which was erroneously initially reported as 06/30/2024.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.